En-Cler Biomedical Waste Management Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 07-07-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.13 Cr
as on 07-07-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 9900.00%
(FY 2022)
- Total Assets 578.01%
(FY 2022)
About En-Cler Biomedical Waste Management
The Company is engaged in the Energy And Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹1.13 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nitin Solanki, Nirav Thakkar, Urvashi Thakkar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2019PTC111780
- Company No.
111780
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at En-Cler Biomedical Waste Management?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Solanki  | Director | 31-Dec-2019 | Current |
| Nirav Thakkar | Director | 31-Dec-2019 | Current |
| Urvashi Thakkar | Director | 31-Dec-2019 | Current |
| Rekha Sarvaiya | Director | 20-Apr-2022 | Current |
| Archit Shah | Director | 20-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of En-Cler Biomedical Waste Management.
En-Cler Biomedical Waste Management Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 9900%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of En-Cler Biomedical Waste Management?
In 2022, En-Cler Biomedical Waste Management had a promoter holding of 97.06% and a public holding of 2.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
En-Cler Biomedical Waste Private Limited
Active
12 years 1 month Nirav Thakkar, Urvashi Thakkar and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jul 2021 | ₹1.13 Cr | Satisfied |
How Many Employees Work at En-Cler Biomedical Waste Management?
Unlock and access historical data on people associated with En-Cler Biomedical Waste Management, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of May 05, 2021, En-Cler Biomedical Waste Management has raised a total of ₹ 1.98 Cr, with the most recent deal valued at ₹ 6.09 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
